GlassScriptPhysician profile
Rodney L Plaster
NPI 1013918788
$60,626.75
in general payments reported to CMS, 2019-2025
7 companies · $3,003 in 2025
The $3,003 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $9,079 · 2021: $11K · 2022: $9,322 · 2023: $7,538 · 2024: $10K · 2025: $3,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $20K · Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,901.70 |
| Food and Beverage | $702.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Total Joint Orthopedics, INC. | $60,091.86 | 2019-2025 | |
| Davol INC. | $188.65 | 2024 | Arista Ah Flexitip |
| Intra-Sana Laboratories | $142.46 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Zimmer Biomet Holdings, INC. | $110.06 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $54.89 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $20.10 | 2024 | Iovera, Zilretta |
| Omnilife Science, INC | $18.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Plaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.